Filter by patients with: All

What is Peginterferon beta-1a?

Category: Prescription Drugs

Most popular types: Plegridy

false

Peginterferon beta-1a may be used for adults with relapsing forms of MS, in which interferon beta-1a is pegylated to extend its half-life which allows less frequent dosing. It is administered once every 14 days via subcutaneous route.

See patients taking Peginterferon beta-1a

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 492 46
Doctor recommendation 3 1
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 565 patients that have taken Peginterferon beta-1a

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 9
Moderate 15
Mild 13
None 10

Commonly reported side effects and conditions associated with Peginterferon beta-1a

Side effect Patients Percentage
Injection site redness 5
Fatigue 3
Fever/chills 3
Headaches 3
Whole body joint ache 3
Extreme flu like malaise 2

Show all 30 reported side effects

Why patients stopped taking Peginterferon beta-1a

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 11
Doctor's advice 3
Did not seem to work 2
Other 2
Change in health plan coverage 1
See all 19 patients who've stopped taking Peginterferon beta-1a

Duration

Stopped taking Peginterferon beta-1a

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 9
6 months - 1 year 5
1 - 2 years 1
5 - 10 years 1
Adherence
Adherence Evaluations Percentage
Always 43
Usually 0
Sometimes 3
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 5
A little hard to take 6
Not at all hard to take 35
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 0
$50-99 2
$25-49 1
< $25 23
Not specified 19

What people switch to and from

Patients started taking Peginterferon beta-1a after stopping:

Treatment Patients Percentage
Interferon beta-1a IM Injection (Avonex) 18
Dimethyl fumarate (Tecfidera) 13
Interferon beta-1a SubQ injection (Rebif) 10
Glatiramer acetate (Copaxone) 8
Natalizumab (Tysabri) 5

Show all 9 treatments patients report switching from

Patients stopped taking Peginterferon beta-1a and switched to:

Treatment Patients Percentage
Teriflunomide (Aubagio) 8
Glatiramer acetate (Copaxone) 6
Dimethyl fumarate (Tecfidera) 2
Interferon beta-1a IM Injection (Avonex) 2
Natalizumab (Tysabri) 2

Show all 7 treatments patients report switching to

Last updated:

1 patient evaluation for Peginterferon beta-1a

Sort by: Most recent

Jan 6, 2016 (Started Apr 15, 2015)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 63 mL Every Other Week

Sep 7, 2015 (Started Apr 15, 2015)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 63 mL Every Other Week
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 2 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Peginterferon beta-1a